{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:31:59Z","timestamp":1761514319661,"version":"3.37.3"},"reference-count":31,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2018,12,28]],"date-time":"2018-12-28T00:00:00Z","timestamp":1545955200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"No funding"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["American J Industrial Med"],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Evidence has associated opioid use initiated early in a workers\u2019 compensation claim with subsequent disability. In 2013, the Washington State Department of Labor and Industries (DLI) implemented procedures based on new regulations that require improvement in pain and function to approve opioids beyond the acute pain period.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We measured opioid prescriptions between 6 and 12 weeks following injury, an indicator of persistent opioid use. Actuarial data for the association of any opioid use versus no opioid use with development of lost time payments are reported.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Prior authorization with hard stops led to a sustained drop in persistent opioid use, from nearly 5% in 2013 to less than 1% in 2017. This reduction was also associated with reversal of the increased lost work time patterns seen from 1999 to 2010.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Prior authorization targeted at preventing transition to chronic opioid use can prevent and reverse adverse time loss development that has occurred on a population basis concomitant with the opioid epidemic.<\/jats:p><\/jats:sec>","DOI":"10.1002\/ajim.22937","type":"journal-article","created":{"date-parts":[[2018,12,28]],"date-time":"2018-12-28T15:03:50Z","timestamp":1546009430000},"page":"168-174","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Brief report: Population\u2010based reversal of the adverse impact of opioids on disability in Washington State workers\u2019 compensation"],"prefix":"10.1002","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1355-4091","authenticated-orcid":false,"given":"Gary M.","family":"Franklin","sequence":"first","affiliation":[{"name":"Washington State Department of Labor and Industries Olympia Washington"},{"name":"Department of Environmental and Occupational Health Sciences University of Washington Seattle Washington"},{"name":"Department of Health Services University of Washington Seattle Washington"},{"name":"Department of Neurology University of Washington Seattle Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Mercier","sequence":"additional","affiliation":[{"name":"Washington State Department of Labor and Industries Olympia Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaymie","family":"Mai","sequence":"additional","affiliation":[{"name":"Washington State Department of Labor and Industries Olympia Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doug","family":"Tuman","sequence":"additional","affiliation":[{"name":"Washington State Department of Labor and Industries Olympia Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Fulton\u2010Kehoe","sequence":"additional","affiliation":[{"name":"Department of Environmental and Occupational Health Sciences University of Washington Seattle Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Wickizer","sequence":"additional","affiliation":[{"name":"Division of Health Services Management and Policy The Ohio State University College of Public Health Columbus Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanne M.","family":"Sears","sequence":"additional","affiliation":[{"name":"Department of Health Services University of Washington Seattle Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,12,28]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm655051e1"},{"key":"e_1_2_12_3_1","unstructured":"Center for Behavioral Health Statistics and Quality.2016. Key substance use and mental health indicators in the United States: Results from the 2015 National Survey on Drug Use and Health (HHS Publication No. SMA 16\u20104984 NSDUH Series H\u201051).https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/NSDUH-FFR1-2016\/NSDUH-FFR1-2016.htmAccessed January 11 2018."},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1508490"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2014.366"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajim.20191"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/BRS.0b013e318160455c"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/BRS.0b013e318145a731"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/BRS.0b013e3181971dea"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/JOM.0b013e3182479fae"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajim.22399"},{"key":"e_1_2_12_12_1","doi-asserted-by":"crossref","unstructured":"FranklinGM. Opioids for chronic non\u2010cancer pain. A position paper of the American Academy of Neurology.Neurology.2014;83:1277\u20131284.","DOI":"10.1212\/WNL.0000000000000839"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2014.302367"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajim.21998"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2015.12.018"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2013.08.001"},{"key":"e_1_2_12_17_1","unstructured":"Washington State Department of Labor and Industries. Guideline for prescribing opioids to treat pain in injured workers. July 1 2013.http:\/\/lni.wa.gov\/ClaimsIns\/Files\/OMD\/MedTreat\/FINALOpioidGuideline010713.pdfAccessed December 7 2017."},{"key":"e_1_2_12_18_1","unstructured":"Washington Administrative Code 296\u201020\u201003055 (Opioid authorization requirement for the acute phase (0\u20106 weeks) and 296\u201020\u201003056 (Opioid authorization requirement for the subacute phase (6\u201012 weeks).http:\/\/app.leg.wa.gov\/wac\/default.aspx?cite=296-20-03055. Accessed January 11 2018."},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmr.2015.04.009"},{"key":"e_1_2_12_20_1","unstructured":"WA Agency Medical Directors Group. Interagency guideline on prescribing opioids for pain. URL:http:\/\/agencymeddirectors.wa.gov\/Files\/2015AMDGOpioidGuideline.pdfAccessed 10\/11\/2018."},{"key":"e_1_2_12_21_1","unstructured":"FriedlandJ.Estimating unpaid claims using basic techniques. Casualty Actuarial Society Third edition. July2010;84\u2013130."},{"key":"e_1_2_12_22_1","first-page":"181","article-title":"The actuary and IBNR","volume":"59","author":"Bornhuetter R","year":"1972","journal-title":"Proc Casualty Actuar Soc"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.1464"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2012.08.007"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000001993"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6610a1"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2559"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.0899"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0b013e3181b01710"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0000000000000183"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2015.1103"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/JOM.0000000000001346"}],"container-title":["American Journal of Industrial Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajim.22937","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajim.22937","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T07:06:37Z","timestamp":1694675197000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajim.22937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,28]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["10.1002\/ajim.22937"],"URL":"https:\/\/doi.org\/10.1002\/ajim.22937","archive":["Portico"],"relation":{},"ISSN":["0271-3586","1097-0274"],"issn-type":[{"type":"print","value":"0271-3586"},{"type":"electronic","value":"1097-0274"}],"subject":[],"published":{"date-parts":[[2018,12,28]]},"assertion":[{"value":"2018-11-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}